Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms
Research output: Contribution to journal › Review › Research › peer-review
Standard
Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms. / Dam, Gitte; Grønbæk, Henning; Sundlöv, Anna; Botling, Johan; Sundin, Anders; Petersen, Rene Horsleben; Welin, Staffan; Evensen, Espen-Thiis; Sorbye, Halfdan; Tabaksblat, Elizaveta; Arveschoug, Anne Kirstine; Mortensen, Jann; Kjaer, Andreas; Knigge, Ulrich; Tiensuu Janson, Eva; Langer, Seppo W.
In: Acta Oncologica, Vol. 62, No. 5, 16.05.2023, p. 431-437.Research output: Contribution to journal › Review › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Nordic 2023 guidelines for the diagnosis and treatment of lung neuroendocrine neoplasms
AU - Dam, Gitte
AU - Grønbæk, Henning
AU - Sundlöv, Anna
AU - Botling, Johan
AU - Sundin, Anders
AU - Petersen, Rene Horsleben
AU - Welin, Staffan
AU - Evensen, Espen-Thiis
AU - Sorbye, Halfdan
AU - Tabaksblat, Elizaveta
AU - Arveschoug, Anne Kirstine
AU - Mortensen, Jann
AU - Kjaer, Andreas
AU - Knigge, Ulrich
AU - Tiensuu Janson, Eva
AU - Langer, Seppo W
PY - 2023/5/16
Y1 - 2023/5/16
N2 - Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work-up and treatment of patients with lung- NEN has undergone major recent advances and new methods are currently being introduced into the clinic. These Nordic guidelines summarize and update the Nordic Neuroendocrine Tumor Group's current view on how to diagnose and treat lung NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients. This review reflects our view of the current state of the art of diagnosis and treatment of patients with lung-NEN. Small cell lung carcinoma (SCLC) is not included in these guidelines.
AB - Lung neuroendocrine neoplasms (NEN) are a heterogeneous population of neoplasms with different pathology, clinical behavior, and prognosis compared to the more common lung cancers. The diagnostic work-up and treatment of patients with lung- NEN has undergone major recent advances and new methods are currently being introduced into the clinic. These Nordic guidelines summarize and update the Nordic Neuroendocrine Tumor Group's current view on how to diagnose and treat lung NEN-patients and are meant to be useful in the daily practice for clinicians handling these patients. This review reflects our view of the current state of the art of diagnosis and treatment of patients with lung-NEN. Small cell lung carcinoma (SCLC) is not included in these guidelines.
U2 - 10.1080/0284186X.2023.2212411
DO - 10.1080/0284186X.2023.2212411
M3 - Review
C2 - 37194281
VL - 62
SP - 431
EP - 437
JO - Acta Oncologica
JF - Acta Oncologica
SN - 1100-1704
IS - 5
ER -
ID: 347317769